Cohance Lifesciences announced that the United States Food and Drug Administration (USFDA) inspected the Company's formulation (FDF) plant located at Shamshabad, Telangana, from 27 August to 4 September 2026.
Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.